Policies

About

The TuBerculosis Vaccine Initiative (TBVI) is a Research and Innovation partnership that works to discover and develop new, safe and effective TB vaccines that are accessible and affordable for all people.

News

WHO launches the Global TB Report 2024

Announcement Awardees | TBVI Awards 2026

Phase 1b/2a clinical trial in adults of novel TB vaccine candidate MTBVAC shows promising results

Email

info@tbvi.eu

Phone

+31 (0) 6 1099 5196

Address

Runderweg 6
8219 PK Lelystad